Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Monoclonal antibodies offer promise in the fight against a wide range of diseases, including COVID-19. The length of the discovery process is a barrier to emergency use, however, and poses a commercial risk for pharmaceutical companies. Multidisciplinary innovation could step up the pace, says Verity Jackson.
Remote user testing allowed us to substantially accelerate the development of the CoVent™ ventilator. Dan Lock reviews the impact of social distancing on user research and finds that many of our necessary adaptations will continue to have value. Yet, each new study challenges us to come up with new approaches to inform medical device development.
To deliver on the promise of greater safety than human drivers, the sensors of autonomous vehicles need to be kept spotlessly clean. Which technology is up to the task, and who will take ownership of what could become a point of competitive advantage in a burgeoning industry, asks Tom Jellicoe.
Autologous cell therapies hold great promise in the treatment of many cancers but are generally produced using processes and equipment for which there are concerns as to whether they are sufficiently reliable to support scale-out to 1000s of systems. Medical device development holds important lessons for achieving the required reliability for cell therapy automation equipment.
TTP consultant, Douglas Bradsahw, was interviewed on Sky News, Ian King Live and discussed CoTest™, TTP's new COVID-19 screening technology to to be used by anyone, anywhere, to screen up to 40 people at once for Covid-19 with results available in 30 minutes.
The Technology Partnership Plc (TTP), a leading independent technology and product development company, is seeking go-to-market partnerships for CoTest, a new pooled screening technology for Covid-19.
Cambridge Half Marathon has announced that Cambridgeshire based independent technology company, TTP, has become the Title Partner of the race ahead of its tenth anniversary in 2021.
TTP CEO, Sam Hyde, was interviewed on BBC Radio 5's Wake up to money programme and discussed the lessons TTP learned from the NHS Ventilator Challenge and their positive impact on the future Healthcare and Medical Device development projects.
